Home › Mutual Funds › Tata Mutual Fund › Tata India Pharma & Healthcare Fund Direct Growth
Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Direct Growth

Add To Compare

35.609 (0.064%)
NAV on December 12, 2025
Category Equity:
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets 1,339 cr
Turnover Ratio 11.18%
Expense Ratio 0.62%
Exit Load 0.25%if redeemed within
30 Days0.00%if redeemed after 30 Days
Returns
  • 1M: -1.34%
  • 1Y: 1.33%
  • 3M: -1.48%
  • 3Y: 23.78%
  • 6M: 2.28%
  • 5Y: 17.71%
Min Investment 5,000
Buy Now Start SIP
ADDITIONAL INFO
Fund Manager Rajat Srivastava (Since about 1 year)
ISIN INF277K019A3
Fund Family Tata
P/E Ratio 42.21
P/B Ratio 6.76
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha 2.62
Beta 0.93
R-Squared 95.14
Info Ratio 0.55
Tracking Err 3.74
Sortino 1.802
Sharpe 0.998
Std Dev 16.061
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 4.36%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 95.64%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

You will not receive any dividends. Your investments will get the largest benefit of compounding.

View Factsheet
-


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata

Data Partner
Click here to visit AMC website and
read all scheme related documents Tata Fund